发布求助
文献互助 智能选刊 最新文献

Cancer Radiotherapie最新文献

筛选
英文 中文
Delineation of target volume by radiation therapists during online adaptive radiation therapy: What authorization? 放射治疗师在在线自适应放射治疗中划定靶区：什么是授权？
IF 1.5 4区 医学
Cancer Radiotherapie Pub Date : 2024-11-01 DOI: 10.1016/j.canrad.2024.07.016
Tiffanie Trouillet, Silouane Poli-Flament, Florence Huguet
{"title":"Delineation of target volume by radiation therapists during online adaptive radiation therapy: What authorization?","authors":"Tiffanie Trouillet,&nbsp;Silouane Poli-Flament,&nbsp;Florence Huguet","doi":"10.1016/j.canrad.2024.07.016","DOIUrl":"10.1016/j.canrad.2024.07.016","url":null,"abstract":"<div><div>The evolution of radiation therapy techniques goes hand in hand with the evolution of the profession of radiation therapist. In the particular context of online adaptive radiotherapy based on cone beam computed tomography images, delegation of certain tasks from the physician to the radiation therapist is possible within the framework of a cooperation protocol. This delegation requires prior theoretical and practical training. It enriches the practice of radiation therapists by allowing them to acquire new skills and greater autonomy. It foreshadows access for radiation therapists to advanced practice.</div></div>","PeriodicalId":9504,"journal":{"name":"Cancer Radiotherapie","volume":"28 6","pages":"Pages 565-567"},"PeriodicalIF":1.5,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142378729","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Salvage reirradiation for locally recurrent prostate cancer: A narrative review 局部复发前列腺癌的挽救性再照射：叙述性综述。
IF 1.5 4区 医学
Cancer Radiotherapie Pub Date : 2024-11-01 DOI: 10.1016/j.canrad.2024.07.008
Juliette Jacques , Mario Terlizzi
{"title":"Salvage reirradiation for locally recurrent prostate cancer: A narrative review","authors":"Juliette Jacques ,&nbsp;Mario Terlizzi","doi":"10.1016/j.canrad.2024.07.008","DOIUrl":"10.1016/j.canrad.2024.07.008","url":null,"abstract":"<div><div>In this narrative review, we will explore the different options for salvage re-irradiation for locally recurrent prostate cancer. Brachytherapy (BT) and stereotactic body radiation therapy (SBRT) appear to be successful options. We detailed doses, volumes, oncological outcomes, and toxicity events to identify the best salvage strategy. Salvage reirradiation can only be proposed in certain cases, depending on the patient and the clinical scenario. Specific imaging and tests are needed to safely deliver this treatment.</div></div>","PeriodicalId":9504,"journal":{"name":"Cancer Radiotherapie","volume":"28 6","pages":"Pages 576-579"},"PeriodicalIF":1.5,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142402337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Issue Contents 议题内容
IF 1.5 4区 医学
Cancer Radiotherapie Pub Date : 2024-11-01 DOI: 10.1016/S1278-3218(24)00176-8
{"title":"Issue Contents","authors":"","doi":"10.1016/S1278-3218(24)00176-8","DOIUrl":"10.1016/S1278-3218(24)00176-8","url":null,"abstract":"","PeriodicalId":9504,"journal":{"name":"Cancer Radiotherapie","volume":"28 6","pages":"Pages e11-e12"},"PeriodicalIF":1.5,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142552939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preoperative stereotactic radiotherapy for the management of brain metastases 治疗脑转移瘤的术前立体定向放射治疗。
IF 1.5 4区 医学
Cancer Radiotherapie Pub Date : 2024-11-01 DOI: 10.1016/j.canrad.2024.07.006
Julian Biau , Florent Guillemin , Angeline Ginzac , Julie Villa , Gilles Truc , Delphine Antoni , Clara Le Fèvre , François Thillays
{"title":"Preoperative stereotactic radiotherapy for the management of brain metastases","authors":"Julian Biau ,&nbsp;Florent Guillemin ,&nbsp;Angeline Ginzac ,&nbsp;Julie Villa ,&nbsp;Gilles Truc ,&nbsp;Delphine Antoni ,&nbsp;Clara Le Fèvre ,&nbsp;François Thillays","doi":"10.1016/j.canrad.2024.07.006","DOIUrl":"10.1016/j.canrad.2024.07.006","url":null,"abstract":"<div><div>Traditionally, postoperative whole-brain radiation therapy (WBRT) has been used for resected brain metastases, reducing local and intracerebral relapses. However, WBRT is associated with cognitive deterioration. Postoperative stereotactic radiotherapy (SRT) has emerged due to its neurocognitive preservation benefits. Despite its advantages, postoperative SRT has several drawbacks, including difficulties in target volume delineation, increased risk of radionecrosis (RN) and leptomeningeal disease (LMD), and prolonged treatment duration. Preoperative SRT has been proposed as a potential alternative, offering promising results in retrospective studies. Retrospective studies have suggested that preoperative SRT could achieve high local control rates with fewer LMD and RN rates compared to postoperative SRT. However, preoperative SRT is primarily based on retrospective data, and no phase 2/3 trials have been published to date. Ongoing clinical trials are expected to provide further insights into the efficacy and safety of preoperative SRT, addressing key questions regarding fractionation, dose, and timing relative to surgery.</div></div>","PeriodicalId":9504,"journal":{"name":"Cancer Radiotherapie","volume":"28 6","pages":"Pages 534-537"},"PeriodicalIF":1.5,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142367863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Essais qui changent les pratiques : cancers urologiques [改变实践的试验：泌尿放射肿瘤学]。
IF 1.5 4区 医学
Cancer Radiotherapie Pub Date : 2024-11-01 DOI: 10.1016/j.canrad.2024.07.010
Pierre Graff , Pascal Pommier , Mathieu Minsat , Gilles Créhange
{"title":"Essais qui changent les pratiques : cancers urologiques","authors":"Pierre Graff ,&nbsp;Pascal Pommier ,&nbsp;Mathieu Minsat ,&nbsp;Gilles Créhange","doi":"10.1016/j.canrad.2024.07.010","DOIUrl":"10.1016/j.canrad.2024.07.010","url":null,"abstract":"<div><div>Herein, we provide a non-exhaustive selection of the main clinical trials presented in 2023–2024 related to radiation-oncology used in the treatment of urological cancers including prostate cancer (radiotherapy of localized prostate cancer, post-prostatectomy irradiation, reirradiation, biochemical recurrence following local treatment, radiotherapy for metastatic cancer), muscle invasive bladder cancer and primary kidney cancer.</div></div>","PeriodicalId":9504,"journal":{"name":"Cancer Radiotherapie","volume":"28 6","pages":"Pages 513-518"},"PeriodicalIF":1.5,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142395955","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial intelligence and radiotherapy: Evolution or revolution? 人工智能与放射治疗：进化还是革命？
IF 1.5 4区 医学
Cancer Radiotherapie Pub Date : 2024-11-01 DOI: 10.1016/j.canrad.2024.09.003
Charlotte Robert , Philippe Meyer , Brigitte Séroussi , Thomas Leroy , Jean-Emmanuel Bibault
{"title":"Artificial intelligence and radiotherapy: Evolution or revolution?","authors":"Charlotte Robert ,&nbsp;Philippe Meyer ,&nbsp;Brigitte Séroussi ,&nbsp;Thomas Leroy ,&nbsp;Jean-Emmanuel Bibault","doi":"10.1016/j.canrad.2024.09.003","DOIUrl":"10.1016/j.canrad.2024.09.003","url":null,"abstract":"<div><div>The integration of artificial intelligence, particularly deep learning algorithms, into radiotherapy represents a transformative shift in the field, enhancing accuracy, efficiency, and personalized care. This paper explores the multifaceted impact of artificial intelligence on radiotherapy, the evolution of the roles of radiation oncologists and medical physicists, and the associated practical challenges. The adoption of artificial intelligence promises to revolutionize the profession by automating repetitive tasks, improving diagnostic precision, and enabling adaptive radiotherapy. However, it also introduces significant risks, such as automation bias, verification failures, and the potential erosion of clinical skills. Ethical considerations, such as maintaining patient autonomy and addressing biases in artificial intelligence systems, are critical to ensuring the responsible use of artificial intelligence. Continuous training and development of robust quality assurance programs are required to mitigate these risks and maximize the benefits of artificial intelligence in radiotherapy.</div></div>","PeriodicalId":9504,"journal":{"name":"Cancer Radiotherapie","volume":"28 6","pages":"Pages 503-509"},"PeriodicalIF":1.5,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142483057","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Personalized strategies for brachytherapy of cervix cancer 宫颈癌近距离放射治疗的个性化策略。
IF 1.5 4区 医学
Cancer Radiotherapie Pub Date : 2024-11-01 DOI: 10.1016/j.canrad.2024.09.006
Guillaume Camprodon , Alexandra Gabro , Zineb El Ayachi , Supriya Chopra , Remi Nout , Philippe Maingon , Cyrus Chargari
{"title":"Personalized strategies for brachytherapy of cervix cancer","authors":"Guillaume Camprodon ,&nbsp;Alexandra Gabro ,&nbsp;Zineb El Ayachi ,&nbsp;Supriya Chopra ,&nbsp;Remi Nout ,&nbsp;Philippe Maingon ,&nbsp;Cyrus Chargari","doi":"10.1016/j.canrad.2024.09.006","DOIUrl":"10.1016/j.canrad.2024.09.006","url":null,"abstract":"<div><div>Among most tailored approaches in radiation oncology, the development of brachytherapy for the treatment of cervical cancer patients has benefited from various technological innovations. The development of 3D image-guided treatments was the first step for treatment personalization. This breakthrough preceded practice homogenization and validation of predictive dose and volume parameters and prognostic factors. We review some of the most significant strategies that emerged from the ongoing research in order to increase personalization in uterovaginal brachytherapy. A better stratification based on patients and tumors characteristics may lead to better discriminate candidates for intensification or de-escalation strategies, in order to still improve patient outcome while minimizing the risk of treatment-related side effects.</div></div>","PeriodicalId":9504,"journal":{"name":"Cancer Radiotherapie","volume":"28 6","pages":"Pages 610-617"},"PeriodicalIF":1.5,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142483059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reirradiation of bone metastasis: A narrative review of the literature 骨转移瘤的再照射：文献综述
IF 1.5 4区 医学
Cancer Radiotherapie Pub Date : 2024-11-01 DOI: 10.1016/j.canrad.2024.07.009
Emma Agnoux , William Gehin , Anaïs Stefani , Vincent Marchesi , Nicolas Martz , Jean-Christophe Faivre
{"title":"Reirradiation of bone metastasis: A narrative review of the literature","authors":"Emma Agnoux ,&nbsp;William Gehin ,&nbsp;Anaïs Stefani ,&nbsp;Vincent Marchesi ,&nbsp;Nicolas Martz ,&nbsp;Jean-Christophe Faivre","doi":"10.1016/j.canrad.2024.07.009","DOIUrl":"10.1016/j.canrad.2024.07.009","url":null,"abstract":"<div><div>Patients with bone metastasis are prevalent among those receiving palliative radiotherapy (RT), with approximately 20 % requiring reirradiation (reirradiation). The goal of bone reirradiation may be local control (oligoreoccurrence or oligoprogression of a previously treated lesion or in a previous treatment field) or symptomatic (threatening or painful progression). Published data on bone reirradiation indicate almost two-thirds of overall pain response. The primary organ at risk (especially for spine treatment) is the spinal cord. The risk of radiation myelitis is<!--> <!-->&lt;<!--> <!-->1 % for cumulative doses of<!--> <!-->&lt;<!--> <!-->50<!--> <!-->Gy. Intensity-modulated RT (IMRT) and stereotactic RT (SRT) appear to be safer than three-dimensional RT (3DRT), although randomized trials comparing these techniques in reirradiation are lacking. Reirradiation requires multidisciplinary assessment. Alternative treatments for bone metastases (surgery, interventional radiology, etc.) must be considered. Patients should have a performance status<!--> <!-->≤<!--> <!-->2, with at least a 1-month interval between treatments. The planning process involves reviewing previous RT plans, cautious dose adjustments, and precise target delineation and dose distribution to minimize toxicity. Cumulative dosimetry, patient consent, and vigilant post-treatment monitoring and dose reporting are crucial.</div></div>","PeriodicalId":9504,"journal":{"name":"Cancer Radiotherapie","volume":"28 6","pages":"Pages 568-575"},"PeriodicalIF":1.5,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142402335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reirradiation of squamous cell carcinoma of the head and neck with external photons: A practical review of the literature 使用外部光子对头颈部鳞状细胞癌进行再照射：文献综述。
IF 1.5 4区 医学
Cancer Radiotherapie Pub Date : 2024-11-01 DOI: 10.1016/j.canrad.2024.07.011
Élodie Queyrel , Arianne Lapierre , Yoann Pointreau , Michel Lapeyre , Julian Biau , Amandine Ruffier
{"title":"Reirradiation of squamous cell carcinoma of the head and neck with external photons: A practical review of the literature","authors":"Élodie Queyrel ,&nbsp;Arianne Lapierre ,&nbsp;Yoann Pointreau ,&nbsp;Michel Lapeyre ,&nbsp;Julian Biau ,&nbsp;Amandine Ruffier","doi":"10.1016/j.canrad.2024.07.011","DOIUrl":"10.1016/j.canrad.2024.07.011","url":null,"abstract":"<div><div>The modalities of management by reirradiation for recurrence or a second localization of head and neck squamous cell carcinoma (HNSCC) in previously irradiated terrain is challenging due to the great heterogeneity of data in the literature, mainly retrospective data reporting non-negligible risks of serious late toxicity events. With the recent development of more precise and conformal radiotherapy techniques such as intensity modulated radiotherapy (IMRT), volumetric modulated arc therapy (VMAT), stereotactic radiotherapy (SBRT), the benefit-to-risk ratio of reirradiation has evolved in recent years with encouraging results, but patient selection is crucial. The aim of this review is to discuss the role of HNSCC reirradiation in terms of patient selection and external photon radiotherapy techniques for definitive tumor reirradiation and postoperative reirradiation.</div></div>","PeriodicalId":9504,"journal":{"name":"Cancer Radiotherapie","volume":"28 6","pages":"Pages 580-585"},"PeriodicalIF":1.5,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142402336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Brain metastases reirradiation 脑转移瘤再放射。
IF 1.5 4区 医学
Cancer Radiotherapie Pub Date : 2024-11-01 DOI: 10.1016/j.canrad.2024.09.005
Claire Petit , Agnès Tallet
{"title":"Brain metastases reirradiation","authors":"Claire Petit ,&nbsp;Agnès Tallet","doi":"10.1016/j.canrad.2024.09.005","DOIUrl":"10.1016/j.canrad.2024.09.005","url":null,"abstract":"<div><div>The advances in cancer screening and therapies have allowed the improvement of metastatic patients’ survival, including those with brain metastases. This led to a substantial shift in brain metastases patients’ management for whom whole-brain radiation therapy, formerly widely used, has given way to a more focused management in which single- or multifractionated stereotactic radiation therapy now plays a predominant role. Although stereotactic radiation therapy offers excellent local control rates (70 to 90%), it does not prevent brain recurrence outside the radiation field, which is all the more frequent the higher the number of initial metastases and the longer the patient's survival. In the case of brain recurrence after irradiation, therapeutic options will depend both on the previous treatment and on the features of the recurrence. This article aims to review the available data on the efficacy and tolerability of various reirradiation schemes in different clinical situations.</div></div>","PeriodicalId":9504,"journal":{"name":"Cancer Radiotherapie","volume":"28 6","pages":"Pages 538-546"},"PeriodicalIF":1.5,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142483058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信